Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Gene Editing Tool Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the global gene editing tool market looks promising with opportunities in cell line engineering, genetic engineering, diagnostics, and drug delivery & development applications. The global gene editing tool market is expected to grow with a CAGR of 16%-18% from 2020 to 2025. The major drivers for this market are increasing prevalence of genetic diseases, rising research and development activities, and rising preference of personalized medicines.
 
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global gene editing tool market report, please download the report brochure.

 
 



In this market, CRISPR is the largest technology of gene editing tool, whereas genetic engineering is the largest application. Growth in various segments of the gene editing tool market are given below:
 


 



The study includes trends and forecast for the global gene editing tool market by product and service, technology, disease application, application, end user, and region as follows:
 
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Reagents & Consumables
  • Software Systems
  • Services 

By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
  • CRISPR
  • Talen
  • ZFN
  • Antisense
  • Other Technologies 

By Disease Application [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Sickle Cell Disease
  • Heart Disease
  • Diabetes
  • Alzheimer’s Disease
  • Obesity
  • Others 

By Application [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostic Applications
  • Drug Discovery & Development
  • Other Applications 

By End User [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Biotech and Pharma Companies
  • Clinical Research Organizations
  • Academic & Research Institutes 
  • Others

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
    • United States
    • Canada 
    • Mexico
  • Europe
    • United Kingdom
    • Spain
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil
 
Some of the gene editing tool companies profiled in this report includes Thermo Fisher Scientific, ERS Genomics, CRISPR Therapeutics, Merck, Editas Medicine, Takara Bio, New England Biolabs, Intellia Therapeutics, GenScript Biotech, and National Human Genome Research Institute.
 
Lucintel forecasts that CRISPR (clustered regularly interspaced short palindromic repeats) will remain the largest technology segment over the forecast period, as it is easy to use as compared to other technologies, and it has an advantage of tailor-made option specific to a patient’s mutations for diseases, like cystic fibrosis.
Within this market, biotech and pharma companies will remain the largest segment by end user over the forecast period due to increasing prevalance of cancer & infectious diseases and increasing research & development activities. 
 
North America will remain the largest region over the forecast period due to increasing genetic diseases and growing pharmaceutical and biotechnology industry in the region.




 
Features of the Global Gene Editing Tool Market
 
  • Market Size Estimates: Global gene editing tool market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global gene editing tool market size by various segments, such as product and service, technology, disease application, application, and end user, in terms of value.
  • Regional Analysis: Global gene editing tool market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different products and services, technologies, disease applications, applications, end users, and regions for the global gene editing tool market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global gene editing tool market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.



 
This report answers following key questions
 
Q.1 What are some of the most promising potential, high-growth opportunities for the global gene editing tool market by product and service (reagents & consumables, software systems, and services), technology (CRISPR, talen, ZFN, antisense, and other technologies), disease application (sickle cell disease, heart disease, diabetes, alzheimer’s disease, obesity, and others), application (cell line engineering, genetic engineering, diagnostic applications, drug discovery & development, and other applications), end user (biotech and pharma companies, clinical research organizations, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global gene editing tool market?
Q.5 What are the business risks and threats to the global gene editing tool market?
Q.6 What are the emerging trends in the gene editing tool market and the reasons behind them?
Q.7 What are some changing demands of customers in the gene editing tool market?
Q.8 What are the new developments in the gene editing tool market? Which companies are leading these developments?
Q.9 Who are the major players in the gene editing tool market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in the gene editing tool market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global gene editing tool market?

 


Report Scope





Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates)		 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecast, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Ventures, and Company Profiling
Market Segments Product and Service (Reagents & Consumables, Software Systems, and Services), Technology (CRISPR, Talen, ZFN, Antisense, and Other Technologies), Disease Application (Sickle Cell Disease, Heart Disease, Diabetes, Alzheimer’s Disease, Obesity, and Others), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, and Other Applications), and End User (Biotech and Pharma Companies, Clinical Research Organizations, Academic & Research Institutes, and Others)

Regional Scope

North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost

Table of Contents
 
 
1. Executive Summary
 
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Gene Editing Tool Market Trends and Forecast
3.3: Global Gene Editing Tool Market by Product and Service
3.3.1: Reagents & Consumables
3.3.2: Software Systems
3.3.3: Services
3.4: Global Gene Editing Tool Market by Technology
3.4.1: CRISPR
3.4.2: Talen
3.4.3: ZFN
3.4.4: Antisense
3.4.5: Other Technologies
3.5: Global Gene Editing Tool Market by Disease Application
3.5.1: Sickle Cell Disease
3.5.2: Heart Disease
3.5.3: Diabetes
3.5.4: Alzheimer’s Disease
3.5.5: Obesity
3.5.6: Others
3.6: Global Gene Editing Tool Market by Application
3.6.1: Cell Line Engineering
3.6.2: Genetic Engineering
3.6.3: Diagnostic Applications
3.6.4: Drug Discovery & Development
3.6.5: Other Applications
3.7: Global Gene Editing Tool Market by End User
3.7.1: Biotech and Pharma Companies 
3.7.2: Clinical Research Organizations
3.7.3: Academic & Research Institutes
3.7.4: Others

4. Market Trends and Forecast Analysis by Region
4.1: Global Gene Editing Tool Market by Region
4.2: North American Gene Editing Tool Market
4.2.1: Market by Product and Service: Reagents & Consumables, Software Systems, and Services
4.2.2: Market by Technology: CRISPR, Talen, ZFN, Antisense, and Other Technologies 
4.2.3: Market by Disease Application: Sickle Cell Disease, Heart Disease, Diabetes, Alzheimer’s Disease, Obesity, and Others
4.2.4: Market By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, And Other Applications 
4.2.5: Market by End User: Biotech and Pharma Companies, Clinical Research Organizations, Academic & Research Institutes, and Others 
4.2.6: The United States Gene Editing Tool Market
4.2.7: The Canadian Gene Editing Tool Market
4.2.8: The Mexican Gene Editing Tool Market
4.3: European Gene Editing Tool Market
4.3.1: Market by Product and Service: Reagents & Consumables, Software Systems, and Services 
4.3.2: Market by Technology: CRISPR, Talen, ZFN, Antisense, and Other Technologies 
4.3.3: Market by Disease Application: Sickle Cell Disease, Heart Disease, Diabetes, Alzheimer’s Disease, Obesity, and Others 
4.3.4: Market by Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, And Other Applications 
4.3.5: Market by End User: Biotech and Pharma Companies, Clinical Research Organizations, Academic & Research Institutes, and Others 
4.3.6: The Gene Editing Tool Market of the United Kingdom
4.3.7: The Spanish Gene Editing Tool Market
4.3.8: The German Gene Editing Tool Market
4.3.9: The French Gene Editing Tool Market
4.4:APAC Gene Editing Tool Market
4.4.1: Market by Product and Service: Reagents & Consumables, Software Systems, and Services 
4.4.2: Market by Technology: CRISPR, Talen, ZFN, Antisense, and Other Technologies 
4.4.3: Market by Disease Application: Sickle Cell Disease, Heart Disease, Diabetes, Alzheimer’s Disease, Obesity, and Others 
4.4.4: Market by Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, And Other Applications 
4.4.5: Market by End User: Biotech and Pharma Companies, Clinical Research Organizations, Academic & Research Institutes, and Others 
4.4.6: The Chinese Gene Editing Tool Market
4.4.7: The Indian Gene Editing Tool Market
4.4.8: The Japanese Gene Editing Tool Market
4.5: ROW Gene Editing Tool Market
4.5.1: Market by Product and Service: Reagents & Consumables, Software Systems, and Services 
4.5.2: Market by Technology: CRISPR, Talen, ZFN, Antisense, and Other Technologies 
4.5.3: Market by Disease Application: Sickle Cell Disease, Heart Disease, Diabetes, Alzheimer’s Disease, Obesity, and Others 
4.5.4: Market by Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, And Other Applications 
4.5.5: Market by End User: Biotech and Pharma Companies, Clinical Research Organizations, Academic & Research Institutes, and Others 
4.5.6: Brazilian Gene Editing Tool Market

5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Gene Editing Tool Market by Product and Service
7.1.2: Growth Opportunities for the Global Gene Editing Tool Market by Technology
7.1.3: Growth Opportunities for the Global Gene Editing Tool Market by Disease Application
7.1.4: Growth Opportunities for the Global Gene Editing Tool Market by Application
7.1.5: Growth Opportunities for the Global Gene Editing Tool Market by End User
7.1.6: Growth Opportunities for the Global Gene Editing Tool Market by Region
7.2: Emerging Trends in the Global Gene Editing Tool Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Gene Editing Tool Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Gene Editing Tool Market
7.3.4: Certification and Licensing

8. Company Profiles of Leading Players
8.1: Thermo Fisher Scientific Inc. 
8.2: ERS Genomics 
8.3: CRISPR THERAPEUTICS
8.4: Merck KGaA
8.5: Editas Medicine
8.6: Takara Bio USA
8.7: New England Biolabs
8.8: Intellia Therapeutics, Inc. 
8.9: GenScript Biotech Corporation 
8.10: National Human Genome Research Institute
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Gene Editing Tool Market: Trends, Forecast and Competitive Analysis Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Gene Editing Tool Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?